Get started
Work

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients

Year: 2011
Type: article
Abstract: Regadenoson is a selective Adenosine-2A receptor agonist and is used for myocardial perfusion imaging. Dipyridamole causes indirect vasodilation by inhibiting cellular reuptake of adenosine. The purpose of this study was to assess whether regadenoson is a better coronary vasodilator than dipyridamole in normal volunteers and in patients.
DOI: 10.1186/1532-429x-13-s1-p124
Authors: Sujethra Vasu, W Patricia Bandettini, Li-Yueh Hsu, Peter Kellman, Marcus Y Chen, Joel Wilson, Steve Leung, Sujata M Shanbhag, O Julian Booker, Christine Mancini, Jennifer Henry, Tracy Lowrey, Andrew E Arai
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W2046118235
FWCI: 0.23
Cites:
Cited by: 1
Related to: 10